Prothena Corp
PRTA
140 hedge funds and large institutions have $355M invested in Prothena Corp in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 49 reducing their positions, and 18 closing their positions.
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
1% more funds holding
Funds holding: 139 → 140 (+1)
3.69% less ownership
Funds ownership: 94.43% → 90.74% (-3.7%)
10% less capital invested
Capital invested by funds: $394M → $355M (-$39.6M)
22% less call options, than puts
Call options by funds: $1.6M | Put options by funds: $2.05M
35% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 49
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| 1 |
BlackRock
New York
|
+$8.32M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$6.71M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$6.56M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.11M |
| 5 |
Goldman Sachs
New York
|
+$1.07M |
Top Sellers
PRTA Hedge Fund Activity: Q3 2020 in Review
140 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Prothena Corp (PRTA) for Q3 2020, worth a combined $355M — down 10% from $394M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new PRTA positions and 18 closed out — a net gain of 1 holder — while 32 added to existing stakes and 49 trimmed.
The largest buyer was BlackRock, adding an estimated $8.32M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $7.06M sold.
- 140 institutional investors held Prothena Corp (PRTA) as of Q3 2020, up from 139 in Q2 2020.
- Funds reported $355M of Prothena Corp stock for Q3 2020, down 10% quarter-over-quarter.
- 19 funds opened new Prothena Corp positions in Q3 2020 and 18 closed out, a net change of +1 holder.
- The largest Prothena Corp buyer in Q3 2020 was BlackRock, an estimated $8.32M added.
- The largest Prothena Corp seller in Q3 2020 was Soleus Capital Management, an estimated $7.06M sold.
Based on aggregated 13F filings for Q3 2020.